Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

Financials

SEC Filings

Filing date Form Description View
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML

 

Anchor Link for Quarterly Results

Data provided by Kaleidoscope.